Medication info
Baclofen Tablet (Acyclovir)

Baclofen Tablet (Acyclovir)

Prescription medicationTabletIntravenous injection
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Hubist Pharmaceutical Co., Ltd.
Appearance
Pale blue shield-shaped tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201508407 · Approved 2015.12.23 · Insurance code 628800690

Summary

Main use
Treatment of herpes zoster; treatment and prevention of herpes simplex; treatment of chickenpox in children aged 2 years and older
Who receives it
Adults · Children
Adult administration
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe initial infection. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) It is preferable to start treatment as soon as possible after infection. In cases of recurrence, treatment should be started when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in immunocompetent patients 1) Administer this medicine at 200 mg 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg may be administered twice daily at 12-hour intervals. 2) The dose may subsequently be reduced to 200 mg 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be discontinued periodically every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer this medicine at 200 mg 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer this medicine at 800 mg 5 times daily at approximately 4-hour intervals, except during sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunocompromise or gastrointestinal malabsorption. 3) It is preferable to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Since patients with renal impairment are more susceptible to adverse reactions affecting the nervous system, caution should be exercised, such as by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer this medicine at 200 mg every 12 hours. 2. Treatment of varicella-zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose of this medicine to 800 mg twice daily at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose of this medicine to 800 mg 3 times daily at approximately 8-hour intervals.
Child administration
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) 2 years and older: Same as for adults. 2) Under 2 years: Administer 1/2 the adult dose. 3) There are currently no reliable data on the prevention of herpes simplex virus infections in immunocompetent patients. 2. Treatment of chickenpox in children aged 2 years and older: Administer this medicine at 20 mg/kg body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment is most effective when started as soon as possible after the chickenpox rash appears; administer within 24 hours after the rash appears, if possible.

Ingredients

Manufacturer
Hubist Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of herpes zoster; treatment and prevention of herpes simplex; treatment of chickenpox in children aged 2 years and older

  • Primary genital herpes
  • recurrent genital herpes
  • herpes simplex virus infection
  • varicella zoster virus infection
  • acute pain
  • chickenpox
View approved original text

This medication is used to treat and prevent infections caused by herpes simplex virus, including primary and recurrent genital herpes, as well as infections occurring on the skin and mucous membranes. It is particularly effective in alleviating acute pain associated with herpes zoster virus infections. However, its efficacy for postherpetic neuralgia has not been clearly demonstrated. It is also used in the treatment of chickenpox in children aged over 2 years. Thus, it is effective for treating various types of viral infections and helps improve the patient's symptoms.

How it is given

Adult administration

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe initial infection. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) It is preferable to start treatment as soon as possible after infection. In cases of recurrence, treatment should be started when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in immunocompetent patients 1) Administer this medicine at 200 mg 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg may be administered twice daily at 12-hour intervals. 2) The dose may subsequently be reduced to 200 mg 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be discontinued periodically every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer this medicine at 200 mg 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer this medicine at 800 mg 5 times daily at approximately 4-hour intervals, except during sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunocompromise or gastrointestinal malabsorption. 3) It is preferable to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Since patients with renal impairment are more susceptible to adverse reactions affecting the nervous system, caution should be exercised, such as by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer this medicine at 200 mg every 12 hours. 2. Treatment of varicella-zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose of this medicine to 800 mg twice daily at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose of this medicine to 800 mg 3 times daily at approximately 8-hour intervals.

Child administration

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) 2 years and older: Same as for adults. 2) Under 2 years: Administer 1/2 the adult dose. 3) There are currently no reliable data on the prevention of herpes simplex virus infections in immunocompetent patients. 2. Treatment of chickenpox in children aged 2 years and older: Administer this medicine at 20 mg/kg body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment is most effective when started as soon as possible after the chickenpox rash appears; administer within 24 hours after the rash appears, if possible.

Precautions

This medication should not be used in patients who have allergies to this medication or its components, or have had hypersensitivity reactions to valacyclovir. Caution is required when used in patients with poor kidney function, as neurological symptoms may more easily manifest. Patients with impaired liver function should also be cautious, as there is a risk of worsening liver function when using this medication. Young infants and children should use this medication carefully, and particularly in neonates or low birth weight infants, its safety has not been sufficiently established, so it should only be used when necessary. Elderly patients are likely to have reduced kidney function, which can lead to increased blood concentration of this medication and more frequent adverse reactions, thus requiring careful adjustment of dosage and intervals. During treatment with this medication, serious allergic reactions such as anaphylactic shock can rarely occur; if symptoms like blood pressure drop, difficulty breathing, or chest tightness arise, usage should be stopped immediately, and appropriate treatment should be sought. Hypersensitivity reactions such as skin rash, fever, blisters, urticaria, and severe dermatitis may occur, and medication should be discontinued if these symptoms appear. Neurological side effects have been reported, including altered consciousness, disorientation, confusion, hallucinations, seizures, drowsiness, and anxiety, particularly in elderly patients or those with impaired kidney function. The risk of renal toxicity may increase when used concomitantly with medications affecting kidney function, so caution is needed when using in combination. This medication is most effective when taken early in the course of symptoms, ideally within 5 days of skin manifestation for herpes zoster, and within 3 days of onset for chickenpox. Adequate hydration is critical during the treatment period; especially in high-dose therapy, it is important to drink plenty of water to prevent dehydration and reduce the risk of renal toxicity. This medication should only be used in pregnant or potentially pregnant women when the benefits are deemed to outweigh the risks, and breastfeeding should be discontinued during the course of treatment. Overdosage may result in serious symptoms such as agitation, coma, seizures, and lethargy, and may cause kidney damage; in such cases, immediate consultation with medical personnel is required, and blood dialysis may be needed. Caution is needed when engaging in activities that carry risks, such as driving or operating machinery, as side effects like altered consciousness may occur.

Side effects

  • Anaphylactic shock
  • anaphylactoid reactions
  • hypotension
  • respiratory distress
  • chest tightness
  • photosensitivity reactions
  • fixed drug eruption
  • rash
  • fever
  • vesicles
Show 117 more
  • urticarial erythema
  • hives
  • alopecia
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • impaired concentration
  • aggressive behavior
  • depersonalization
  • anxiety
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • convulsions
  • drowsiness
  • tremors
  • agitation
  • amnesia
  • insomnia
  • anxiety
  • solitary speech
  • paresthesia
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalline urine
  • elevated BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • hemorrhage
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • upper abdominal pain
  • gastric pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • fatigue
  • generalized weakness
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • elevated blood pressure
  • decreased blood pressure
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disturbances
  • sweating
  • hyponatremia
  • decreased serum protein
  • elevated total cholesterol
  • elevated triglycerides
  • elevated serum potassium
  • decreased serum albumin
  • anxiety
  • coma
  • convulsions
  • drowsiness
  • confusion
  • hallucinations
  • agitation
  • seizure disorders
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that protects it from light. Additionally, it should be kept in a cool, dry place at or below 25 degrees Celsius to maintain its efficacy.

Appearance and packaging

Appearance

Pale blue shield-shaped tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.